In addition, AABs against the vasoregulatory renin-angiotensin-system (RAS)-related proteins Angiotensin-converting enzyme 2 (ACE2) and angiotensin type-1 receptor (AGTR1) were increased in acute COVID-19 patients and associated with the disease severity (18). Here, ACE2 is linked to COVID-19.